MedTrace Logo

Efficacy of Eductyl® Versus Placebo for Treatment of Dyschesia

NCT00910832 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2014-03-19

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia treated by rectal rehabilitation.

Conditions

  • Dyschesia

Interventions

DRUG

Eductyl suppository

one suppository every morning during 21 days

DRUG

Placebo suppository

placebo suppository every morning during 21 days

Sponsors & Collaborators

  • Laboratoires Techni Pharma

    lead INDUSTRY

Principal Investigators

  • Odile Cotelle, Dr · Diaconesses hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2011-12-31
Completion
2012-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00910832 on ClinicalTrials.gov